Medical weight loss & GLP-1 in Newtown, PA
Physician-supervised, longitudinal, and integrated with the rest of your care — not a standalone med-spa product.
Weight management at Signature Medicine combines GLP-1 medications when clinically indicated (Ozempic, Wegovy, Zepbound, Mounjaro) with an InBody body-composition scan, baseline labs, and regular physician check-ins. The plan is built and managed by Dr. Sitapara as part of your overall preventive care.
What’s included
- Baseline metabolic workup (lipid panel, A1C, fasting insulin, thyroid, comprehensive metabolic panel)
- InBody scan for skeletal muscle mass, visceral fat, segmental analysis — the standard tool to track what is actually changing on a plan
- Personalized plan: medication when indicated, nutrition framing, exercise + resistance training guidance, sleep + stress factors
- GLP-1 prescribing (semaglutide / tirzepatide) for members who meet indications
- Insurance prior-authorization support; out-of-pocket discussion when coverage is denied
- Regular follow-up visits with Dr. Sitapara — not a different provider each call
- Coordination with cardiology, endocrinology, sleep medicine when adjacent issues surface
Why integrated weight management matters
Med-spas and telehealth-only weight-loss programs typically run one-size-fits-all medication protocols without longitudinal physician care. That works for some patients. It produces problems for others — muscle-mass loss that BMI doesn’t catch, cardiovascular risk that no one is tracking, thyroid or sleep apnea that turns out to be doing more of the work than the medication, and prior-authorization fights with no one in your corner.
At Signature Medicine, weight management lives in the same chart as your annual labs, cardiovascular workup, and specialist referrals. Dr. Sitapara reviews progress at every visit and adjusts the plan based on body composition, not just the scale.
How to start
Members can ask Dr. Sitapara to add weight management to their care plan at any visit. Prospective members: schedule a complimentary consultation to discuss whether the practice is the right fit. See pricing for what is included in membership and what is billed separately (medications, advanced screening) at preferred-member rates.
Frequently Asked Questions
Does Signature Medicine prescribe GLP-1 medications like Ozempic and Wegovy?
Yes, when clinically appropriate. Dr. Sitapara prescribes FDA-approved GLP-1 medications (semaglutide / Ozempic, Wegovy; tirzepatide / Zepbound, Mounjaro) for members who meet the indications and prefer a physician-supervised program rather than a med-spa or telehealth-only model.
What does physician-supervised weight management include at Signature Medicine?
A baseline metabolic and body-composition workup, an InBody scan to anchor the plan to muscle mass and visceral fat (not just bathroom-scale weight), a personalized medication and nutrition plan when indicated, regular check-ins, and labs at the cadence the clinical evidence supports. The program is integrated into your overall care, not a standalone product.
Is the medication covered by my insurance?
Coverage varies by plan and indication. Some commercial plans cover GLP-1s for type 2 diabetes; coverage for obesity is more variable. We help patients navigate prior authorization where possible and discuss out-of-pocket options when coverage is denied.
How is this different from a med-spa or online weight-loss program?
Med-spa and telehealth-only weight-loss programs typically run one-size-fits-all medication protocols without a longitudinal physician relationship. Signature Medicine integrates weight management into your overall preventive care — your cardiovascular risk, thyroid function, sleep, body composition, and prescription interactions are all in the same chart and reviewed by the same doctor.
Do you work with people who have already plateaued on a GLP-1?
Yes. Many members come to us mid-program after a plateau on a starter dose or after a med-spa or telehealth prescriber dropped follow-up. Dr. Sitapara reviews the regimen, body-composition changes, and adjacent labs to decide whether dose, lifestyle, or sequencing changes are clinically warranted.
Last reviewed by Dr. Ashish Sitapara, MD, FACP on